Switch to:

Ascendis Pharma A/S EV-to-EBIT

: -26.57 (As of Today)
View and export this data going back to 2015. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ascendis Pharma A/S's Enterprise Value is USD 4,814.44 Mil. Ascendis Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was USD -181.22 Mil. Therefore, Ascendis Pharma A/S's EV-to-EBIT for today is -26.57.

NAS:ASND' s EV-to-EBIT Range Over the Past 10 Years
Min: -29.6   Max: -3.6
Current: -26.57

-29.6
-3.6

During the past 8 years, the highest EV-to-EBIT of Ascendis Pharma A/S was -3.60. The lowest was -29.60. And the median was -11.30.

NAS:ASND's EV-to-EBIT is ranked lower than
99.99% of the 271 Companies
in the Biotechnology industry.

( Industry Median: 19.73 vs. NAS:ASND: -26.57 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ascendis Pharma A/S's Enterprise Value for the quarter that ended in Sep. 2019 was USD 3,913.59 Mil. Ascendis Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was USD -181.22 Mil. Ascendis Pharma A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 was -4.63%.


Ascendis Pharma A/S EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ascendis Pharma A/S Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only 0.00 -8.86 -6.16 -8.73 -15.99

Ascendis Pharma A/S Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.13 -15.99 -29.05 -24.46 -21.60

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Ascendis Pharma A/S EV-to-EBIT Distribution

* The bar in red indicates where Ascendis Pharma A/S's EV-to-EBIT falls into.



Ascendis Pharma A/S EV-to-EBIT Calculation

Ascendis Pharma A/S's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4814.443/-181.215852669
=-26.57

Ascendis Pharma A/S's current Enterprise Value is USD 4,814.44 Mil.
Ascendis Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was -36.3959044369 (Dec. 2018 ) + -60.4666666667 (Mar. 2019 ) + -57.0338983051 (Jun. 2019 ) + -27.3193832599 (Sep. 2019 ) = USD -181.22 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Ascendis Pharma A/S  (NAS:ASND) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ascendis Pharma A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2019 =EBIT / Enterprise Value (Q: Sep. 2019 )
=-181.215852669/3913.58882643
=-4.63 %

Ascendis Pharma A/S's Enterprise Value for the quarter that ended in >Sep. 2019 was USD 3,913.59 Mil.
Ascendis Pharma A/S's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was -36.3959044369 (Dec. 2018 ) + -60.4666666667 (Mar. 2019 ) + -57.0338983051 (Jun. 2019 ) + -27.3193832599 (Sep. 2019 ) = USD -181.22 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Ascendis Pharma A/S EV-to-EBIT Related Terms


Ascendis Pharma A/S EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */